67 web-programmer-developer-university-of-liverpool Postdoctoral positions at Yale University
Sort by
Refine Your Search
-
Postdoctoral position Posting Date: 7/29/2024 Yale School of Medicine Department of Emergency Medicine The Data Mining (DM) Lab at Yale University lead by Dr. Samah Fodeh has an opening for a
-
Anticipated Appointment Dates: 3/1/2025 Email/Website: Wendy.agudo@yale.edu (Program Manager) https://medicine.yale.edu/psychiatry/research/programs/center-science-cannabis-cannabinoids/ Introduction of School
-
program of training will also include both attendance at departmental workshops and seminars. They will present their results at weekly Fredericks Lab meetings, join in our weekly journal club, and be
-
acquired DNA alterations in normal cells and in cancer development. The successful applicant will work independently, perform experiments, develop and optimise assays, and analyse, interpret, and present
-
Position: Postdoctoral Associate Employer: Inclusion Economics at Yale University Location: New Haven, CT, USA Inclusion Economics at Yale University, led by Professor Rohini Pande, Henry J. Heinz
-
. Opportunities for presentations at local, regional, and national meetings, manuscript writing, grant preparation, and professional development. Qualifications: MD, PhD, PharmD, or equivalent degree. Background in
-
: - Develop and implement AI models to study and optimize TCR and BCR interactions, enhancing receptor design for improved binding affinity, specificity, and therapeutic effectiveness. - Collaborate with
-
Postdoctoral Positions in Mucosal Immunity and Intestinal Inflammation (Dr. Clara Abraham) Investigator: Clara Abraham, MD Mucosal Immunity and Intestinal Inflammation Yale University, New Haven, CT
-
to improving outcomes for students and aligns with its work to develop public education leaders. Unlike many postdoctoral opportunities in education, this associateship is a unique opportunity for education
-
are one of the most exciting areas of cancer biology. Many novel strategies for targeting RAS are in clinical trial, and many more are in development and are advancing to clinical trials. The Stites lab’s